Skip to main content

Korro Bio, Inc.

KRRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001703647

In the last 90 days, Korro Bio, Inc. insiders filed 1 open-market purchase and 8 sales; 106 institutions reported holding it in 13F filings for Q2 2026, worth $190.1M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Korro Bio, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of KRRO: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders8884−4
Shares18.6M17.7M−908.9K (−4.9%)
Value$130.4M$90.2M−$40.2M (−30.8%)

New holders (21)

Institutions that held Korro Bio, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to KRRO in Q4 2021
InstitutionSharesValue% of portfolio
Jacobs Levy Equity Management, Inc317,837$1.63M0.01%
Bridgeway Capital Management, LLC88,700$455.0K0.01%
Millennium Management LLC56,654$291.0K0.00%
Anson Funds Management LP42,534$218.0K0.03%
Nomura Holdings Inc34,360$181.0K0.00%
Cresset Asset Management, LLC30,000$154.0K0.00%
Virtu Financial LLC25,010$128.0K0.01%
Squarepoint Ops LLC20,611$106.0K0.00%
Jump Financial, LLC15,288$78.0K0.00%
Renaissance Technologies LLC13,400$69.0K0.00%
Simplex Trading, LLC4,559$23.0K0.00%
Group One Trading, L.P.1,796$9.00K0.00%
Quadrant Capital Group LLC1,830$9.00K0.00%
TD Waterhouse Canada Inc.1,450$7.74K0.00%
Eagle Bay Advisors LLC987$5.00K0.00%
Aquatic Capital Management LLC700$4.00K0.01%
CWM, LLC300$2.00K0.00%
Retirement Planning Co of New England, Inc.400$2.00K0.00%
Capital Advisors, Ltd. LLC182$1.00K0.00%
FMR LLC3$00.00%
Toronto Dominion Bank4$00.00%

Sold out (25)

Institutions that held Korro Bio, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.